肿瘤中心总支副书记、肿瘤Ⅰ科书记兼主任

善于运用最先进的理论、循证医学证据和高端放疗、靶向、免疫、化疗等手段，精准诊治胸部肿瘤、消化系统肿瘤、泌尿生殖系统肿瘤；崇尚科学、规范、人性的医疗理念，与欧美多家机构合作开展多项临床研究。

中国抗癌协会（CACA）肺癌专业委员会委员； 中国抗癌协会（CACA）肿瘤放射治疗专委会肺癌学组委员 ； 中国临床肿瘤学会（CSCO）肿瘤生物标志物专委会委员； 华人放疗协作组（CRTOG）肺癌专委会委员； 中国老年保健学会肺癌专业委员会常委； 湖北省医学会肿瘤学分会常委 ； 湖北省临床肿瘤学会（ESCO）第二届理事会常务理事 ； 湖北省临床肿瘤学会（ESCO）肺癌专委会常委； 湖北省临床肿瘤学会（ESCO）肺癌青年专委会主委； 湖北省临床肿瘤学会（ESCO）纵隔肿瘤专委会副主委； 湖北省临床肿瘤学会（ESCO）分子影像专委会常委； 湖北省临床肿瘤学会（ESCO）食管癌专委会常委； 湖北省肿瘤专科联盟第一届理事会副理事长； 湖北省抗癌协会第八届理事会常务理事； 湖北省抗癌协会肿瘤内科治疗专委会副主委； 湖北省抗癌协会肿瘤营养与代谢专委会副主委 ； 湖北省抗癌协会肺癌专委会常委兼秘书 ； 获湖北省自然科学优秀学术论文二等奖1项；黄石市科技进步二等奖1项；武汉大学人民医院“医疗菁英”、“人民抗疫英模”等荣誉。

1、YG Li#, J Chen#, B Wang#, ZW Xu, C Wu, JF Ma, QB Song, Q Geng, JM Yu*, HD Pei*, Y Yao*. FOXK2 affects cancer cell response to chemotherapy by promoting nucleotide de novo synthesis. Drug Resist Update. 2023, 67: 100926.

2、SJ He#, S Zhang#, Y Yao#, et al. Turbulence of Glutamine Metabolism in Pan-cancer Prognosis and Immune Microenvironment. Front Oncol. 2022, 12: 1064127.

3、ZY Zhang#, Y Dong#, B Wu#, YG Li, ZH Liu, ZM Liu, YJ Gao, LK Gao, QB Song*, ZL Zheng*, Y Yao*. Irradiation enhances the malignancy-promoting behaviors of cancer-associated fibroblasts. Front Oncol. 2022, 12: 965660

4、Y Yao, J Zhou, HH Zhang, et al. Identification and validation for biological characteristic and prognosis of tumor microenvironment subtypes in patients with lung adenocarcinoma. J Clin Oncol. 2022, 40(16 suppl): e21006

5、HH Zhang#, Y Yao#, J Wu#, et al. Comprehensive analysis identifies and validates the tumor microenvironment subtypes to predict anti-tumor therapies efficacy in Hepatocellular carcinoma. Front Immunol. 2022; 13: 838374

6、Y Dong#, YG Li#, Y Yao*, et al. A novel defined m7G regulator signature to investigate the association between molecular characterization and clinical significance in lung adenocarcinoma. Front Oncol. 2022, 12: 897323.

7、ZM Liu, J Wang, FB Liao, QB Song, Y Yao*. Tumor-educated platelets facilitate thrombus formation through migration. Front Oncol. 2022, 12: 857865.

8、SQ Yang#, Y Yao#,*, Y Dong, et al. Predict radiation pneumonitis using a genome-scale flux analysis on RNA-seq derived from peripheral blood. Front Med. 2021, 8: 715961

9、B Xu#, KH Song#, Y Yao#, et al. Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study. Cancer Sci. 2021, 112(6): 2522-2532.

10、Y Yao#, YX Chu#, B Xu, et al. Risk factors for distant metastasis of patients with primary triple-negative breast cancer. Biosci Rep. 2019, 39(6): BSR20190288.

11、SF Ye#, XF Chen#, Y Yao#,*, et al. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study. Sci Rep. 2019, 9(1): 2652 

12、Y Yao#, YX Chu#, B Xu, et al. Radiotherapy after surgery has significant survival benefits for patients with triple negative breast cancer. Cancer Med. 2019, 8(2): 554-563. 

13、Y Yao#,*, M Peng#, QL Shen#, et al. Detecting EGFR Mutations and ALK/ROS1 Rearrangements in Non-Small Cell Lung Cancer Using Malignant Pleural Effusion Samples. Thorac Cancer. 2019, 10(2): 193-202

14、Zhang C#, Zeng WF#, Yao Yi#, et al. Naringenin ameliorates radiation-induced lung injury by lowering IL-1β level. J Pharmacol Exp Ther. 2018, 366(2): 341-348. 

15、Yao Y#,*, Zheng ZL, Song QB. Mesenchymal stem cells: a double-edged sword in radiation-induced lung injury. Thorac Cancer. 2018, 9(2): 208-217.